Personalized vaccine for advanced solid tumors after standard treatments fail
Part of Cancer clinical trials.
This trial offers access to a personalized vaccine made from your tumor's unique markers (neoantigens). The goal is to train your immune system to fight your cancer. You may qualify if standard treatments have not worked or are not an option, and your doctor believes your 5-year survival chance is under 50%.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years old or older.
- You have a solid tumor that has spread or is locally advanced, and you have already tried or can't take the standard FDA-approved treatments.
- Your doctor expects your chance of living 5 more years to be less than 50%.
- You are in reasonably good health otherwise (able to do daily activities, with adequate organ function).
- You do not have a serious allergy to vaccines or a condition that severely weakens your immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized cancer vaccine made from synthetic long peptide “neoantigens,” aiming to be safe and help the immune system fight certain solid tumors. It may fit people with pancreatic cancer after starting first-line chemotherapy, and some other solid tumors with limited options.
This trial tests a personalized vaccine made from your cancer's unique markers. The goal is to train your immune system to fight the cancer, potentially slowing it down when other options have run out.
This trial tests a personalized cancer vaccine made from your own immune cells to help your body fight the tumor. It is for people with solid tumors that have not responded to other treatments.
This trial tests a personalized vaccine made from unique markers on your tumor cells (called neoantigens). The goal is to help your immune system fight the cancer more effectively. It is for people with advanced solid tumors who have not had gene therapy and are otherwise relatively healthy.
This trial tests a personalized vaccine made from “neoantigens” (tumor-specific targets) to help your immune system fight advanced, inoperable solid tumors. It may be an option if standard treatment didn’t work or you stopped it and your health is strong enough for trial treatment.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.